Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Interferon Induction in Human Leukocytes after in vitro Exposure to Cytomegalovirus or Epstein-Barr Virus

Interferon Induction in Human Leukocytes after in vitro Exposure to Cytomegalovirus or... Interferon (IFN) was produced after exposure of human mononuclear leukocytes and bone marrow cells to infectious or noninfectious cytomegalovirus (CMV) in vitro. The IFN was generated mainly by non-B lymphocytes. Both α- and γ-type IFN could be demonstrated. CMV antigens were usually not demonstrable in CMV-exposed leukocytes. Addition of anti-IFN antibodies did not induce CMV antigens. Thus, it seems that the endogenous production of IFN is not responsible for the difficulties in demonstrating CMV antigens after in vitro exposure of normal human leukocytes to CMV. Addition of Epstein-Barr virus (EBV) B95–8 to leukocytes induced the production of α-type IFN. Exogenously added IFN reduced the induction of EBV-determined nuclear antigen (EBNA). However, the presence of anti-IFN antibodies in EBV-infected cultures did not increase the number of EBNA-positive cells. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Intervirology Karger

Interferon Induction in Human Leukocytes after in vitro Exposure to Cytomegalovirus or Epstein-Barr Virus

Intervirology , Volume 23 (3): 10 – Jan 1, 2008

Loading next page...
 
/lp/karger/interferon-induction-in-human-leukocytes-after-in-vitro-exposure-to-SCczdFK39d

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Karger
Copyright
© 1985 S. Karger AG, Basel
ISSN
0300-5526
eISSN
1423-0100
DOI
10.1159/000149597
Publisher site
See Article on Publisher Site

Abstract

Interferon (IFN) was produced after exposure of human mononuclear leukocytes and bone marrow cells to infectious or noninfectious cytomegalovirus (CMV) in vitro. The IFN was generated mainly by non-B lymphocytes. Both α- and γ-type IFN could be demonstrated. CMV antigens were usually not demonstrable in CMV-exposed leukocytes. Addition of anti-IFN antibodies did not induce CMV antigens. Thus, it seems that the endogenous production of IFN is not responsible for the difficulties in demonstrating CMV antigens after in vitro exposure of normal human leukocytes to CMV. Addition of Epstein-Barr virus (EBV) B95–8 to leukocytes induced the production of α-type IFN. Exogenously added IFN reduced the induction of EBV-determined nuclear antigen (EBNA). However, the presence of anti-IFN antibodies in EBV-infected cultures did not increase the number of EBNA-positive cells.

Journal

IntervirologyKarger

Published: Jan 1, 2008

Keywords: Interferon; Human leukocytes; Cytomegalovirus; Epstein-Barr virus

There are no references for this article.